Horm Metab Res 2005; 37(2): 106-110
DOI: 10.1055/s-2005-861175
Original Clinical
© Georg Thieme Verlag KG Stuttgart · New York

Optimizing Insulin Sensitivity Assessment Using the Minimal Model in Chronic Heart Failure

W.  Doehner 1 , S.  D.  Anker 1, 2 , I.  F.  Godsland 3
  • 1Applied Cachexia Research, Dept of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Humboldt University, Berlin, Germany
  • 2Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London, U.K.
  • 3Endocrinology and Metabolic Medicine, Division of Medicine, Imperial College London, London, U.K.
Weitere Informationen

Publikationsverlauf

Received 1 June 2004

Accepted after revision 13 September 2004

Publikationsdatum:
21. März 2005 (online)

Abstract

Background: Minimal model analysis of the intravenous glucose tolerance test (IVGTT) has been used successfully to demonstrate that patients with chronic heart failure (CHF) are insulin-resistant. Continuing experience in minimal model methodology has raised questions about how best to assign basal glucose concentrations during such analyses. Methods and Results: IVGTT data from randomly selected patients with CHF (n = 15) and controls (n = 15) were analysed using the minimal model, with the basal glucose concentration (Gb) assigned the value of fasting plasma glucose concentration (Gfast), or the value of plasma glucose concentration 180 minutes after the start of the IVGTT (G180). Insulin sensitivity (SI) was significantly higher with Gb = Gfast, than with Gb = G180 (controls: 5.60 ± 0.78 vs. 3.36 ± 0.25/min/μU/ml x 104, p = 0.0017; patients 4.19 ± 0.54 vs. 2.36 ± 0.15/min/μU/ml x 104, p = 0.0004). At Gb = Gfast, CHF patients showed a non-significant 25 % reduction in SI in comparison to controls (p = 0.15). In contrast, at Gb = G180, CHF patients showed a significant 30 % reduction of SI in comparison to controls (p = 0.0018). SI estimates derived at Gb = Gfast exhibited twice the variability of those estimated using Gb = G180 (coefficients of variation of SI in patients with CHF were 50.0 % and 24.8 %, respectively). Conclusion: In studies of patients with CHF, greater precision and discriminatory power of insulin sensitivity estimates is obtained when the basal glucose concentration is taken as the plasma glucose concentration 180 minutes after the start of the IVGTT.

References

  • 1 Swan J W, Anker S D, Walton C, Godsland I F, Clark A L, Leyva F. et al . Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.  J Amer Coll Cardiol. 1997;  30 527-532
  • 2 Doehner W, Rauchhaus M, Godsland I F, Egerer K, Niebauer J, Sharma R. et al . Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.  Int J Cardiol. 2002;  83 73-81
  • 3 Doehner W, Godsland I F, Rauchhaus M, Ponikowski P P, Coats A JS, Anker S D. Insulin resistance and survival in chronic heart failure.  J Am Coll Cardiol. 2003;  41 (suppl A) 158A
  • 4 Bergman R N, Ider Y Z, Bowden C R, Cobelli C. Quantitative estimation of insulin sensitivity.  Am J Physiol. 1979;  236 E667-E677
  • 5 Swan J, Walton C, Godsland I F. Assessment of insulin sensitivity in man: a comparison of minimal model and euglycaemic clamp derived measures in health and heart failure.  Clin Sci. 1994;  86 317-322
  • 6 Godsland I F. The minimal model: an evolving methodology.  Clin Sci. 2003;  105 531-532
  • 7 Perez-Martin A, Raynaud E, Hentgen C, Bringer J, Mercier J, Brun J F. Simplified measurement of insulin sensitivity with the minimal model procedure in type 2 diabetic patients without measurement of insulinemia.  Horm Metab Res.. 2002;  34 102-106
  • 8 Welch S, Gebhart S, Bergman R, Philips L. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.  J Clin Endocrinol Metab. 1990;  71 1508-1518
  • 9 Coates P A, Ollerton R L, Luzio S D, Ismail I S, Owens D R. Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM.  Diabetes. 1993;  42 1635-1641
  • 10 Caumo A C, Cobelli C. Hepatic glucose production during the labelled IVGTT: estimation by deconvolution with a new minimal model.  Am J Physiol. 1993;  264 E829-E841
  • 11 Godsland I F, Walton C. Maximising the success rate of minimal model insulin sensitivity measurement in humans: the importance of basal glucose levels.  Clin Sci. 2001;  101 1-9
  • 12 Swan J W, Walton C, Godsland I F, Clark A L, Coats A JS, Oliver M F. Insulin resistance in chronic heart failure.  Eur Heart J. 1994;  15 1528-1532
  • 13 Suskin N, McKelvie R S, Burns R J, Latini R, Pericak D, Probstfield J. et al . Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.  Eur Heart J. 2000;  21 1368-1375
  • 14 Paolisso G, De Rui S, Matrrazzo G, Verza M, Varricchio M, D'Onofrio F. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.  Metabolism. 1991;  40 972-977

W. Doehner, M. D., Ph. D.

Division of Applied Cachexia Research, Dept of Cardiology Charité Medical School

Campus Virchow-Klinikum · Humboldt University · Augustenburger Platz 1 · 13353 Berlin · Germany ·

Telefon: +49 (30) 450 553 507

Fax: +49 (30) 450 553 951

eMail: wolfram.doehner@charite.de

    >